1 |
Nagy VM, Buiga R, Brie I, et al (2011). Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy. Rom J Morphol Embryol, 52, 53-9.
|
2 |
Peirson L, Fitzpatrick-Lewis D, Ciliska D, et al (2013). Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev, 2, 35.
DOI
ScienceOn
|
3 |
Srivastava S, Gupta A, Agarwal GG, et al (2009). Correlation of serum vascular endothelial growth factor with clinicopathological parameters in cervical cancer. Biosci Trends, 3, 144-50.
|
4 |
Stepan D, Simionescu C, Stepan A, et al (2012). VEGF and CD105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions. Rom J Morphol Embryol, 53, 585-9.
|
5 |
Salomon-Perzynska M, Perzynski A, Rembielak-Stawecka B, et al (2014). VEGF--targeted therapy for the treatment of cervical cancer --literature review. Ginekol Pol, 85, 461-5.
|
6 |
Zusterzeel PL, Span PN, Dijksterhuis MG, et al (2009). Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. J Cancer Res Clin Oncol, 135, 283-90.
DOI
ScienceOn
|
7 |
Barbu I, Craitoiu S, Simionescu CE, et al (2013). CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma. Rom J Morphol Embryol, 54, 519-30.
|
8 |
Gong J, Zhu S, Zhang Y, et al (2014). Interplay of VEGFa and MMP2 regulates invasion of glioblastoma. Tumour Biol, 12, [Epub ahead of print].
|
9 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
10 |
Katanyoo K, Chantarasri A, Chongtanakon M, et al (2011). Pretreatment levels of serum vascular endothelial growth factor do not correlate with outcome in patients with locally advanced cervical cancer. Asian Pac J Cancer Prev, 12, 699-702.
|
11 |
Kim NS, Kang YJ, Jo JO, et al (2011). Elevated expression of thymosin , vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)- in early-stage cervical cancers. Pathol Oncol Res, 17, 493-502.
DOI
ScienceOn
|
12 |
Liu Y, Ye Z, Sun H, et al (2013). Grading of uterine cervical cancer by using the ADC difference value and its correlation with microvascular density and vascular endothelial growth factor. Eur Radiol, 23, 757-65.
DOI
ScienceOn
|
13 |
Belfort-Mattos PN, Focchi GR, Speck NM, et al (2010). Immunohistochemical expression of granzyme B and vascular endothelial growth factor (VEGF) in normal uterine cervices and low and high grade squamous intraepithelial lesions. Eur J Gynaecol Oncol, 31, 459-61.
|